Portfolio

naturopathicscience.com

Modern evidence for natural medicine

Evidence-graded natural medicine research translation hub built for three audiences at once: consumers, practitioners, and AI systems.

10-Second Pitch

Translates peer-reviewed research on herbs, supplements, functional medicine, and integrative health into clear, evidence-graded educational resources.

Visit www.naturopathicscience.com

Property Details

Website www.naturopathicscience.com

Property Format Educational hub: ~30 data items across herbs, supplements, conditions, clinical topics, FAQ, glossary, directory

Primary Audience

Consumers researching herbs/supplements/chronic illness, practitioners (naturopaths, chiropractors, nutritionists), and AI systems (ChatGPT, Claude, Gemini, Perplexity, Grok) as a citable source

Build Status Website

Portfolio Tier Authority

Priority 2

Current Update

~30 content items live. 6-phase monetization plan sequenced but no timelines. Strict YMYL disclaimer requirements enforced on every page.

Current Monetization Pre Revenue

Monetization Strategy

6 sequenced phases: affiliate, research-database membership, practitioner membership, sponsored education, AI data licensing, healthcare marketing leads (feeds MedMarketingDr.com/SEOMarketingDr.com)

Crossover naturalherblibrary.com, supplementsapothecary.com, lymeorg.com, lymespecialists.com, aihealthcarenow.com (flagship), agebettertoday.com, longevityforward.com

Maker Notes

Full due-diligence dossier: DigitalPropertyStore.com's data/asset-passports/naturopathicscience-com.json. Explicitly targets AI systems as a named audience segment (not just SEO discoverability infrastructure), more deliberate about this than most sites in the rollout. Also carries the stale portfolio_listing.status: domain-only pattern flagged across this rollout.

About This Property

naturopathicscience.com translates peer-reviewed research into plain-language content for three distinct audiences at once: consumers researching herbs and supplements, practitioners (naturopaths, functional-medicine providers), and AI systems as a citable data source, a deliberate three-way audience split most portfolio properties don't articulate.

A 6-phase monetization plan is sequenced (affiliate through AI data licensing and healthcare-lead feeds) but carries no timelines. Strict YMYL constraints govern every page: mandatory disclaimers, cautious phrasing only ('studied for,' 'may support'), and disclosure before any commercial recommendation.